{"id":"https://openalex.org/W2097092276","doi":null,"title":"Phase I study of an antisense oligonucleotide to protein kinase C-alpha (ISIS 3521/CGP 64128A) in patients with cancer.","display_name":"Phase I study of an antisense oligonucleotide to protein kinase C-alpha (ISIS 3521/CGP 64128A) in patients with cancer.","publication_year":1999,"publication_date":"1999-11-01","ids":{"openalex":"https://openalex.org/W2097092276","mag":"2097092276","pmid":"https://pubmed.ncbi.nlm.nih.gov/10589745"},"language":"en","primary_location":{"id":"pmid:10589745","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10589745","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112255195","display_name":"Alan R. Yuen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A R Yuen","raw_affiliation_strings":["Oncology Division, Stanford University School of Medicine, California 94305, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Division, Stanford University School of Medicine, California 94305, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026246540","display_name":"Joanne Halsey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Halsey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036188351","display_name":"George Albert Fisher","orcid":"https://orcid.org/0000-0002-6828-3938","observed_orcids":["https://orcid.org/0000-0002-6828-3938"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G A Fisher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022275011","display_name":"John T Holmlund","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J T Holmlund","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056554811","display_name":"Richard S. Geary","orcid":"https://orcid.org/0000-0002-6308-3179","observed_orcids":["https://orcid.org/0000-0002-6308-3179"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R S Geary","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007490829","display_name":"T. Jesse Kwoh","orcid":"https://orcid.org/0009-0003-8726-3996","observed_orcids":["https://orcid.org/0009-0003-8726-3996"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T J Kwoh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011633842","display_name":"Andrew Dorr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Dorr","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019649110","display_name":"Branimir Ivan Sikic","orcid":"https://orcid.org/0000-0001-6814-2070","observed_orcids":["https://orcid.org/0000-0001-6814-2070"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B I Sikic","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.0222,"has_fulltext":false,"cited_by_count":146,"citation_normalized_percentile":{"value":0.94983314,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"5","issue":"11","first_page":"3357","last_page":"63"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.49779999256134033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.49779999256134033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.13259999454021454,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.041099999099969864,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protein-kinase-c-alpha","display_name":"protein kinase C alpha","score":0.8090000152587891},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9229999780654907},{"id":"https://openalex.org/keywords/phosphorothioate-oligodeoxynucleotides","display_name":"phosphorothioate oligodeoxynucleotides","score":0.9789999723434448},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.6690000295639038},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9089999794960022},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8650000095367432},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.8899999856948853},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9589999914169312},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9129999876022339},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.902999997138977},{"id":"https://openalex.org/keywords/continuous-intravenous-infusion","display_name":"continuous intravenous infusion","score":0.7419999837875366},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6763631701469421},{"id":"https://openalex.org/C195794163","wikidata":"https://www.wikidata.org/wiki/Q420877","display_name":"Protein kinase C","level":3,"score":0.641503095626831},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6028982400894165},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5879387259483337},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5656209588050842},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.56419438123703},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5406761169433594},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.513202428817749},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4094267189502716},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3935832679271698},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24547094106674194},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08012324571609497},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001483","descriptor_name":"Base Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011493","descriptor_name":"Protein Kinase C","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013873","descriptor_name":"Thionucleotides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014057","descriptor_name":"Tomography, X-Ray Computed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020319","descriptor_name":"Oligodeoxyribonucleotides, Antisense","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D020319","descriptor_name":"Oligodeoxyribonucleotides, Antisense","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D020319","descriptor_name":"Oligodeoxyribonucleotides, Antisense","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D051571","descriptor_name":"Protein Kinase C-alpha","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10589745","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10589745","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},{"id":"mag:2097092276","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10589745","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1517879977","https://openalex.org/W1550494424","https://openalex.org/W1595712017","https://openalex.org/W1605224674","https://openalex.org/W1821878109","https://openalex.org/W1993282564","https://openalex.org/W2036801946","https://openalex.org/W2044422939","https://openalex.org/W2062575651","https://openalex.org/W2080853378","https://openalex.org/W2095952487","https://openalex.org/W2106898231","https://openalex.org/W2135368384","https://openalex.org/W2338282341","https://openalex.org/W2403381121","https://openalex.org/W2409979703","https://openalex.org/W2412069333"],"related_works":["https://openalex.org/W7099387497","https://openalex.org/W1546496348","https://openalex.org/W2248643920","https://openalex.org/W2147478255","https://openalex.org/W2042594798","https://openalex.org/W2409163532","https://openalex.org/W2406675254","https://openalex.org/W2119792005","https://openalex.org/W2031730270","https://openalex.org/W2090507662"],"abstract_inverted_index":{"Protein":[0],"kinase":[1],"C":[2],"(PKC)":[3],"is":[4,12,215],"an":[5],"attractive":[6],"target":[7],"in":[8,14,50,53,81,149,197,247],"cancer":[9,249],"therapy.":[10],"It":[11],"overexpressed":[13],"a":[15,90,101,112,168,221],"variety":[16],"of":[17,22,48,72,103,131,170,183,187,199,208,223,232,237],"cancers,":[18],"and":[19,40,52,65,142,165,179,230,234,250],"nonspecific":[20],"inhibitors":[21],"PKC":[23],"have":[24,34],"demonstrated":[25],"antitumor":[26,238],"activity.":[27],"Antisense":[28],"oligonucleotides":[29],"targeted":[30],"against":[31],"PKC-alpha,":[32],"which":[33],"high":[35],"specificity,":[36],"can":[37],"inhibit":[38],"mRNA":[39],"protein":[41],"expression":[42],"as":[43,45],"well":[44],"the":[46,62,68,127,241],"growth":[47],"tumors":[49],"vitro":[51],"vivo.":[54],"This":[55],"Phase":[56,212,244],"I":[57],"study":[58,128],"sought":[59],"to":[60,66,74,121,192],"characterize":[61],"safety":[63],"profile":[64],"determine":[67],"maximum":[69,154],"tolerated":[70,155],"dose":[71,156,169,207],"antisense":[73],"PKC-alpha":[75],"when":[76,218],"administered":[77],"by":[78,106,111],"continuous":[79,107],"infusion":[80,109],"patients.":[82],"Patients":[83,124],"with":[84,202],"incurable":[85],"malignancies":[86],"received":[87],"ISIS":[88,184,209],"3521,":[89],"20-length":[91],"phosphorothioate":[92],"oligodeoxynucleotide":[93],"specific":[94],"for":[95,211,243],"PKC-alpha.":[96],"Treatment":[97],"was":[98,137,157,195],"delivered":[99],"over":[100,220],"period":[102,222],"21":[104,145,224],"days":[105],"i.v.":[108],"followed":[110],"7-day":[113],"rest":[114],"period.":[115],"Doses":[116],"were":[117,147,163],"increased":[118],"from":[119],"0.5":[120],"3.0":[122,171],"mg/kg/day.":[123,159,172],"continued":[125],"on":[126],"until":[129],"evidence":[130],"disease":[132],"progression":[133],"or":[134],"unacceptable":[135],"toxicity":[136],"detected.":[138],"Between":[139],"August":[140],"1996":[141],"September":[143],"1997,":[144],"patients":[146,201],"treated":[148],"five":[150],"patient":[151],"cohorts.":[152],"The":[153,160,205],"2.0":[158,216],"dose-limiting":[161],"toxicities":[162],"thrombocytopenia":[164,233],"fatigue":[166],"at":[167],"Pharmacokinetic":[173],"measurements":[174],"showed":[175],"rapid":[176],"plasma":[177],"clearance":[178],"dose-dependent":[180],"steady-state":[181],"concentrations":[182],"3521.":[185],"Evidence":[186,236],"tumor":[188],"response":[189],"lasting":[190],"up":[191],"11":[193],"months":[194],"observed":[196],"three":[198],"four":[200],"ovarian":[203,248],"cancer.":[204],"recommended":[206],"3521":[210],"II":[213,245],"studies":[214,246],"mg/kg/day":[217],"given":[219],"days.":[225],"Side":[226],"effects":[227],"are":[228],"modest":[229],"consist":[231],"fatigue.":[235],"activity":[239],"provides":[240],"rationale":[242],"other":[251],"malignancies.":[252]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}